Open Beta
MetriLume

US marketsHRGN

SEC-sourced researchBeta

HRGN

Harvard Apparatus Regenerative Technology, Inc.

Company comparison ↗

Data passport

CIK
0001563665
Exchange
OTC
Business activity
— · SIC 3841
Financial inputs
6/6
Filing date
Sep 25, 2026
SEC registry record
Operating company

Annual financial history

Up to three published annual periods. The chart shows financial statement amounts; missing observations are not connected. Each company chart uses its own scale; compare amounts in the table.

Up to three published annual periods. The chart shows financial statement amounts; missing observations are not connected. Each company chart uses its own scale; compare amounts in the table. Exact amounts and source periods: December 2024: 430,000.0000 USD; December 2025: 704,000.0000 USD704K USD0 USD0December 2024December 2025
HRGN · Exact amounts and source periods · USD
Period endRevenueFiling date
December 2024430,000.0000Mar 19, 2026
December 2025704,000.0000Mar 19, 2026

Annual periods · USD

Period endRevenueNet incomeOperating cash flowTotal assetsTotal liabilitiesFiling date
December 2025704,000.0000-6,869,000.0000-3,828,000.00002,677,000.00001,620,000.0000Mar 19, 2026
December 2024430,000.0000-7,732,000.0000-4,852,000.00004,442,000.00001,220,000.0000Mar 19, 2026

Financial inputs behind the calculation

Financial inputsUSDPeriod endFiling dateForm
RevenueRevenueFromContractWithCustomerExcludingAssessedTax$704KDecember 2025Mar 19, 202610-K
Previous period revenueRevenueFromContractWithCustomerExcludingAssessedTax$430KDecember 2024Mar 19, 202610-K
Net incomeNetIncomeLoss-$6.87MDecember 2025Mar 19, 202610-K
Operating cash flowNetCashProvidedByUsedInOperatingActivities-$3.83MDecember 2025Mar 19, 202610-K
Total assetsAssets$2.68MDecember 2025Mar 19, 202610-K
Total liabilitiesLiabilities$1.62MDecember 2025Mar 19, 202610-K

New filings

Explore methodology ↗